Health
Study confirms rare blood clotting risk linked to ChAdOx1-S vaccine – benefits still outweigh risks – News-Medical.Net
New research published in BMJ confirmed evidence of blood clotting finding a small risk after receiving one Oxford-AstraZeneca ChAdOx1-S severe acute respiratory…
Pharmaceutical and biotechnology company AstraZeneca had recently come under fire for rare blood clotting events — causing a temporary suspension of the vaccine in multiple countries. In April, the European Medicines Agency concluded the vaccine is potentially linked to blood clotting in people with low blood platelets who received the dose. However, they emphasized unusual blood clotting was a rare side effect.
New research published in BMJ confirmed evidence of blood clotting finding a small risk…
-
Noosa News23 hours agoBali traveller sparks urgent measles alert across Queensland
-
Noosa News23 hours agoQueensland man sentenced to four years imprisonment after string of terror offences
-
Business23 hours agoThe best ASX ETFs for compounding wealth until 2040
-
Noosa News22 hours agoMeasles alert issued south of Brisbane after traveller tests positive